Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.57%93.761.3%$1006.11m
BIIBBiogen Inc.
-0.35%226.391.3%$952.73m
AMGNAmgen Inc.
-2.74%177.471.3%$455.04m
GILDGilead Sciences, Inc.
-0.47%62.950.9%$420.88m
ILMNIllumina, Inc.
0.11%319.033.5%$281.15m
REGNRegeneron Pharmaceuticals, Inc.
-2.81%333.342.6%$259.19m
VRTXVertex Pharmaceuticals Incorporated
0.71%168.161.9%$237.18m
ALXNAlexion Pharmaceuticals, Inc.
0.08%126.012.0%$169.88m
ONCESpark Therapeutics, Inc.
-0.08%110.6211.2%$168.64m
EXASExact Sciences Corporation
0.44%92.2125.3%$159.86m
SRPTSarepta Therapeutics, Inc.
-1.76%116.6414.7%$145.69m
AAgilent Technologies, Inc.
0.99%76.181.6%$128.52m
INCYIncyte Corporation
-0.48%73.962.5%$95.36m
IONSIonis Pharmaceuticals, Inc.
0.44%72.998.3%$93.24m
BMRNBioMarin Pharmaceutical Inc.
0.98%83.164.3%$89.86m

Company Profile

Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.